Use of non-peptidic nk1 receptor antagonists for the...

Details Use of non-peptidic nk1 receptor antagonists for the... Use of non-peptidic nk1 receptor antagonists for the...

A - Human Necessities

61

K

A61K 31/445 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2566315

The invention relates to the use of substance P antagonists and, in particular, the use of non-peptidic NK1 receptor antagonists for the treatment of cancer and, more specifically, human melanoma, neuroblastoma, glioma, human Hodgkin's lymphoma KM-H2, lymphoblastic leukaemia, human rhabdomyosarcoma, human breast carcinoma, human Burkitt's lymphoma, human lung carcinoma, human Ewing's sarcoma, human glioma and human osteosarcoma.

L'invention concerne l'utilisation des antagonistes de la substance P, notamment l'utilisation des antagonistes non peptidiques des récepteurs NK1 pour le traitement du cancer et, d'une manière plus spécifique, du mélanome humain, du neuroblastome, du gliome, du lymphome d'Hodgkin-KM-H2 humain, de la leucémie lymphoblastique, du rabdomyosarcome humain, du carcinome humain du sein, du lymphome de Burkitt humain, du carcinome humain du poumon, du sarcome humain d'Ewing, du gliome humain et de l'ostéosarcome humain.

Affiliated with

Also associated with

Rating

Use of non-peptidic nk1 receptor antagonists for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of non-peptidic nk1 receptor antagonists for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of non-peptidic nk1 receptor antagonists for the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2023893